238 related articles for article (PubMed ID: 2215853)
1. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: I. Levels of dopamine and metabolites.
Yu ZJ; Lim DK; Hoskins B; Rockhold RW; Ho IK
Neurochem Res; 1990 Jun; 15(6):613-9. PubMed ID: 2215853
[TBL] [Abstract][Full Text] [Related]
2. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: II. Dopamine receptors.
Lim DK; Yu ZJ; Hoskins B; Rockhold RW; Ho IK
Neurochem Res; 1990 Jun; 15(6):621-7. PubMed ID: 2145522
[TBL] [Abstract][Full Text] [Related]
3. Cocaine elevates striatal dopamine efflux in spontaneously hypertensive and Wistar-Kyoto rats.
Inada T; Polk K; Jin C; Purser C; Hume A; Hoskins B; Ho IK; Rockhold RW
Brain Res Bull; 1992 Feb; 28(2):227-31. PubMed ID: 1596742
[TBL] [Abstract][Full Text] [Related]
4. Effects of acute and subacute cocaine administration on the CNS dopaminergic system in Wistar-Kyoto and spontaneously hypertensive rats: III. Dopamine uptake.
Lim DK; Yu ZJ; Hoskins B; Rockhold RW; Ho IK
Neurochem Res; 1990 Jun; 15(6):629-34. PubMed ID: 2215854
[TBL] [Abstract][Full Text] [Related]
5. Cholecystokinin-induced release of dopamine in the nucleus accumbens of the spontaneously hypertensive rat.
Kirouac GJ; Ganguly PK
Brain Res; 1995 Aug; 689(2):245-53. PubMed ID: 7583328
[TBL] [Abstract][Full Text] [Related]
6. Chronic cocaine and rat brain catecholamines: long-term reduction in hypothalamic and frontal cortex dopamine metabolism.
Karoum F; Suddath RL; Wyatt RJ
Eur J Pharmacol; 1990 Sep; 186(1):1-8. PubMed ID: 2282931
[TBL] [Abstract][Full Text] [Related]
7. In vivo basal and amphetamine-induced striatal dopamine and metabolite levels are similar in the spontaneously hypertensive, Wistar-Kyoto and Sprague-Dawley male rats.
Ferguson SA; Gough BJ; Cada AM
Physiol Behav; 2003 Oct; 80(1):109-14. PubMed ID: 14568315
[TBL] [Abstract][Full Text] [Related]
8. Neurochemical evidence that cocaine- and amphetamine-regulated transcript (CART) 55-102 peptide modulates the dopaminergic reward system by decreasing the dopamine release in the mouse nucleus accumbens.
Rakovska A; Baranyi M; Windisch K; Petkova-Kirova P; Gagov H; Kalfin R
Brain Res Bull; 2017 Sep; 134():246-252. PubMed ID: 28802898
[TBL] [Abstract][Full Text] [Related]
9. Site and mechanism of behavioral tolerance to cocaine: a study of dopamine release in Wistar-Kyoto and spontaneously hypertensive rats.
Yu ZJ; Jin C; Rockhold RW; Hoskins B; Ho IK
Neurochem Res; 1993 Nov; 18(11):1203-9. PubMed ID: 8255373
[TBL] [Abstract][Full Text] [Related]
10. Effects of acute and chronic clozapine on dopamine release and metabolism in the striatum and nucleus accumbens of conscious rats.
Invernizzi R; Morali F; Pozzi L; Samanin R
Br J Pharmacol; 1990 Aug; 100(4):774-8. PubMed ID: 2207499
[TBL] [Abstract][Full Text] [Related]
11. Extracellular dopamine and its metabolites in the nucleus accumbens of Fischer and Lewis rats: basal levels and cocaine-induced changes.
Strecker RE; Eberle WF; Ashby CR
Life Sci; 1995; 56(6):PL135-41. PubMed ID: 7530315
[TBL] [Abstract][Full Text] [Related]
12. The nigrostriatal dopamine system: role in the development of hypertension in spontaneously hypertensive rats.
Linthorst AC; van Giersbergen PL; Gras M; Versteeg DH; de Jong W
Brain Res; 1994 Mar; 639(2):261-8. PubMed ID: 8205480
[TBL] [Abstract][Full Text] [Related]
13. Release of dopamine is reduced by diazepam more in the nucleus accumbens than in the caudate nucleus of conscious rats.
Invernizzi R; Pozzi L; Samanin R
Neuropharmacology; 1991 Jun; 30(6):575-8. PubMed ID: 1922681
[TBL] [Abstract][Full Text] [Related]
14. Effect of morphine applied by intrapallidal microdialysis on the release of dopamine in the nucleus accumbens.
Anagnostakis Y; Spyraki C
Brain Res Bull; 1994; 34(3):275-82. PubMed ID: 8055351
[TBL] [Abstract][Full Text] [Related]
15. Neurotensin increases extracellular striatal dopamine levels in vivo.
Chapman MA; See RE; Bissette G
Neuropeptides; 1992 Jul; 22(3):175-83. PubMed ID: 1436404
[TBL] [Abstract][Full Text] [Related]
16. Brain dopamine D-2 receptor mechanisms in spontaneously hypertensive rats.
Van den Buuse M; Jones CR; Wagner J
Brain Res Bull; 1992 Feb; 28(2):289-97. PubMed ID: 1375862
[TBL] [Abstract][Full Text] [Related]
17. Activation of the subthalamic nucleus and pedunculopontine tegmentum: does it affect dopamine levels in the substantia nigra, nucleus accumbens and striatum?
Jaffer A; van der Spuy GD; Russell VA; Mintz M; Taljaard JJ
Neurodegeneration; 1995 Jun; 4(2):139-45. PubMed ID: 7583677
[TBL] [Abstract][Full Text] [Related]
18. Dopamine in the basal ganglia and benzodiazepine-induced sedation.
Brose N; O'Neill RD; Boutelle MG; Fillenz M
Neuropharmacology; 1988 Jun; 27(6):589-95. PubMed ID: 3419542
[TBL] [Abstract][Full Text] [Related]
19. Long-term decreases in striatal dopamine, 3,4-dihydroxyphenylacetic acid, and homovanillic acid after a single injection of amphetamine in iprindole-treated rats: time course and time-dependent interactions with amfonelic acid.
Steranka LR
Brain Res; 1982 Feb; 234(1):123-36. PubMed ID: 7059818
[TBL] [Abstract][Full Text] [Related]
20. The 5-HT1A receptor antagonist (S)-UH-301 decreases dopamine release in the rat nucleus accumbens and striatum.
Nomikos GG; Arborelius L; Höök BB; Hacksell U; Svensson TH
J Neural Transm (Vienna); 1996; 103(5):541-54. PubMed ID: 8811500
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
